Ledger.Open graph →
SEC Form D · filed June 24, 2022

Monod Bio, Inc

Offering
$26.3M
Sold
$24.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

David A. Shoultz · Seattle, WAExec · DirectorDave A. Johnson · Seattle, WADirectorBerta M. Cimler · Seattle, WADirectorDaniel A. Silva Manzano · Seattle, WAExec · DirectorKaran A. Takhar · Seattle, WADirectorWilliam Shang Wi Hsu · Beijing, IsraelDirectorStuart Schonberger · California, X1Exec · DirectorYu Min · Kowloon, Hong KongDirectorGang Li · Kowloon, Hong KongExec · DirectorAlfredo A. Quijano Rubio · Seattle, WAExecDaniel Passov · San Diego, CAExec · DirectorKristopher Armstrong · San Diego, CADirectorJonathan P. Lennon · Rincon, Puerto RicoExec · DirectorWilliam Matthew Grander · Naperville, ILDirectorAlfredo A. Quijano Rubio · Seattle, WAExecKaran A. Takhar · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗